The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

The purpose of the TESLA study is establish the effectiveness of
intra-arterial treatment (IAT). Patients presenting with symptoms of
arterial ischemic stroke who have evidence of a moderate-large
infarct volume [NCCT ASPECTS 2-5] in the anterior circulation will be
assigned to either best medical management alone (including IV
rtPA) or intra-arterial treatment (IAT) with mechanical
thrombectomy added to best medical management. Each treated
patient will be followed and assessed for 3 months after
randomization.